LNGR


Longevity Thematic ETF

Fund Summary

The Global X Longevity Thematic ETF (LNGR) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Longevity Thematic ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index.

Why LNGR?

High Growth Potential

LNGR enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

LNGR's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, LNGR delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 1/18/17

Ticker LNGR
Primary Exchange NASDAQ
CUSIP 37954Y772
ISIN US37954Y7720
Net Assets $1,575,855.61
Management Fee 0.68%
Annual Fund Operating Expense 0.68%
Inception Date 5/9/16
Shares Outstanding 100,000
30-Day SEC Yield 0.80%
Distribution Frequency Annually
Distribution Calendar

Fund Prices

As of 1/18/17
NAV Price
Net Asset Value $15.76 Closing Price $15.80
Daily Change $0.03 0.18% Daily Change $0.01 0.06%

Performance History

Cumulative %

Data as of month end (12/31/16)

Fund NAV Closing Price Index
1 Month 0.87% 1.72% 0.95%
3 Months -7.43% -6.75% -7.31%
6 Months -2.23% -1.40% -1.99%
Since Inception -0.12% 3.01% 0.20%

Cumulative %

Data as of quarter end (12/31/16)

Fund NAV Closing Price Index
Since Inception -0.12% 3.01% 0.20%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized Return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Fund Characteristics As of 1/18/17

Return on Equity 12.40%
Average Market Cap $12,417.00 M
2015 2016
Price-to-earnings 37.80 30.21
Price-to-book value 3.90 3.62

Source: AltaVista Research, LLC

Top 10 Holdings

As of 1/18/17
Net Assets % Name Market Price ($) Shares Held Market Value ($)
3.74 BOSTON SCIENTIFIC CORP 23.92 2,461 58,867.12
3.39 STRYKER CORP 122.40 436 53,366.40
3.32 BECTON DICKINSON AND CO 173.98 301 52,367.98
3.26 CELGENE CORP 115.22 446 51,388.12
3.20 BIOGEN INC 283.61 178 50,482.58
3.15 ABBVIE INC 61.66 805 49,636.30
3.13 INCYTE CORP 115.09 428 49,258.52
3.08 ZIMMER BIOMET HOLDINGS IN 115.47 420 48,497.40
2.99 VENTAS INC 62.22 758 47,162.76
2.98 MEDTRONIC PLC 75.67 621 46,991.07
Holdings are subject to change.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which the Fund may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. In addition to normal risks associated with investing, international investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. The fund is non-diversified which represents a heightened risk to investors.

Shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Global X NAVs are calculated using prices as of 4:00 PM EST. The closing price is the Mid-Point between the Bid and Ask price as of the close of exchange.

Since the Fund’s Shares typically do not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Fund’s full or summary prospectus, which may be obtained by calling 1-888-GX-FUND-1 (1.888.493.8631), or by visiting globalxfunds.com. Read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, FTSE, Standard & Poors, NASDAQ, S-Network, Indxx, or MSCI nor do these companies make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO nor Global X is affiliated with Solactive AG, FTSE, Standard & Poors, NASDAQ, S-Network, Indxx, or MSCI.